ARTICLE SUMMARY:
While FDA, and the US Environmental Protection Agency, are apparently closely collaborating to balance concerns of ethylene oxide emissions from device sterilization and the growing risk of device shortages, it is the state governments that really have the leverage on this issue and must be engaged.
FDA held an advisory panel meeting November 6-7 to address growing concerns of device shortages in the wake of ethylene oxide (EtO) sterilization facility shutdowns. But there was one important voice that was missing from the panel discussion: state governments.
